GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212-2 2 mg/kg and tested on the Elevated Plus-Maze
Cassar, D., Radic, M., Casarrubea, M., Crunelli, V., Di Giovanni, G. (2022). The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze. CNS NEUROSCIENCE & THERAPEUTICS, 28(8), 1268-1270 [10.1111/cns.13848].
The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze
Casarrubea, MaurizioWriting – Review & Editing
;
2022-08-01
Abstract
GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212-2 2 mg/kg and tested on the Elevated Plus-Maze
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022b - CNSNT.pdf
Solo gestori archvio
Descrizione: ahead of print
Tipologia:
Versione Editoriale
Dimensione
1.39 MB
Formato
Adobe PDF
|
1.39 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
CNS Neuroscience Therapeutics - 2022 - Cassar - The effect of cannabinoid receptor agonist WIN 55 212 2 on anxiety‐like.pdf
Solo gestori archvio
Descrizione: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,provided the original work is properly cited
Tipologia:
Versione Editoriale
Dimensione
1.39 MB
Formato
Adobe PDF
|
1.39 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
